Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Authors
de Graaf, HIbrahim, M
Hill, A R
Gbesemete, D
Vaughan, A T
Gorringe, A
Preston, A
Buisman, A M
Faust, S N
Kester, K E
Berbers, G A M
Diavatopoulos, D A
Read, R C
Type
ArticleLanguage
en
Metadata
Show full item recordTitle
Controlled human infection with Bordetella pertussis induces asymptomatic, immunising colonisation.Published in
Clin Infect Dis 2020; 71(2):403-11PMID
31562530ae974a485f413a2113503eed53cd6c53
10.1093/cid/ciz840
Scopus Count
Collections
Related articles
- A phase I clinical study of a live attenuated Bordetella pertussis vaccine--BPZE1; a single centre, double-blind, placebo-controlled, dose-escalating study of BPZE1 given intranasally to healthy adult male volunteers.
- Authors: Thorstensson R, Trollfors B, Al-Tawil N, Jahnmatz M, Bergström J, Ljungman M, Törner A, Wehlin L, Van Broekhoven A, Bosman F, Debrie AS, Mielcarek N, Locht C
- Issue date: 2014
- Azithromycin is as effective as and better tolerated than erythromycin estolate for the treatment of pertussis.
- Authors: Langley JM, Halperin SA, Boucher FD, Smith B, Pediatric Investigators Collaborative Network on Infections in Canada (PICNIC).
- Issue date: 2004 Jul
- Investigating <i>Bordetella pertussis</i> colonisation and immunity: protocol for an inpatient controlled human infection model.
- Authors: de Graaf H, Gbesemete D, Gorringe AR, Diavatopoulos DA, Kester KE, Faust SN, Read RC
- Issue date: 2017 Oct 11
- A controlled study of the relationship between Bordetella pertussis infections and sudden unexpected deaths among German infants.
- Authors: Heininger U, Kleemann WJ, Cherry JD, Sudden Infant Death Syndrome Study Group.
- Issue date: 2004 Jul
- Safety and immunogenicity of the live attenuated intranasal pertussis vaccine BPZE1: a phase 1b, double-blind, randomised, placebo-controlled dose-escalation study.
- Authors: Jahnmatz M, Richert L, Al-Tawil N, Storsaeter J, Colin C, Bauduin C, Thalen M, Solovay K, Rubin K, Mielcarek N, Thorstensson R, Locht C, BPZE1 study team.
- Issue date: 2020 Nov